Method of inhibiting harmful microorganisms and barrier-forming composition therefor
Abstract
A method for blocking, neutralizing, or killing microorganisms that cause infectious disease in a mammal prior to or during the mammal encountering a contaminated environment or item includes: identifying a contaminated environment or item, wherein the contaminated environment or item is known or expected to be contaminated with harmful viral, fungal, or bacterial microorganisms; and administering a therapeutically effective amount of a barrier-forming composition to a mucosa of the mammal prior to or during the mammal encountering the contaminated environment or item. The barrier-forming composition provides a barrier on the mucosa that inhibits the microorganisms from contacting the mucosa. Other related methods are also included.
Claims
exact text as granted — not AI-modifiedIt is claimed:
1 . A method for reducing risk of infectious disease in a host from microorganisms encountered subsequent to application of a barrier-forming composition, the method comprising:
administering by spraying or mouthwash delivery, a therapeutically effective amount of the barrier-forming composition to a mucosa of the host; the composition comprising: about 0.01%≤C≤about 0.4%; 7%≤H≤about 65%; and 0.050%<A; wherein all percentages are by weight of the total composition; wherein C is a carbohydrate gum; H is a humectant; and A is a cationic antimicrobial agents or pharmaceutically acceptable salt thereof; wherein the composition forms a barrier on the mucosa that is active to trap, and kill or neutralize microorganisms; with the proviso that the method is not administered for prevention or treatment of dental disease.
2 . The method of claim 1 , wherein the pH of the composition is about 4 to about 7.
3 . The method of claim 1 , wherein the antimicrobial, A, is present in an amount of 0.050%<A<0.1% by weight of the total composition.
4 . The method of claim 1 , wherein the composition has a broad spectrum antimicrobial property that is effective to kill or neutralize fungal, bacterial, and viral microorganisms.
5 . The method of claim 1 , wherein the composition is in the form of a solution.
6 . The method of claim 1 , wherein the composition is free-flowing and clump free.
7 . The method of claim 1 , wherein the mucosa is an oral or pharyngeal mucosa.
8 . The method of claim 1 , wherein the composition is effective in 80% of humans to show a decrease of about 50% or greater of microbial load in the oral cavity on the sixth day of three times daily administering of the composition.
9 . A method for prevention of infectious disease in a host, the method comprising:
administering a therapeutically effective amount of a composition to a mucosa of the host; the composition comprising: about 0.01%≤C≤0.4%; about 7%≤H≤about 65%; and 0.050%<A; wherein all percentages are by weight of the total composition; wherein C is a carbohydrate gum; H is a humectant; and A is an antimicrobial agent; wherein the infectious disease is caused by an influenza virus.
10 . The method of claim 9 , wherein the mucosa is an oral or pharyngeal mucosa.
11 . The method of claim 9 , wherein the composition is effective in 80% of humans to show a decrease of about 50% or greater of microbial load in the oral cavity on the sixth day of three times daily administering of the composition.
12 . The method of claim 9 , wherein the composition is effective to reduce a microbial load by 65% to 88% in the oral cavity after the administering step.
13 . The method of claim 9 , wherein the composition has a broad spectrum antimicrobial property that is effective to kill or neutralize fungal, bacterial, and viral microorganisms.
14 . The method of claim 1 , wherein the composition is in the form of a solution.
15 . The method of claim 1 , wherein the composition is free-flowing and clump free.
16 . A barrier-forming composition for a surface treatment comprising:
a carbohydrate gum, a humectant, and an antimicrobial agent; wherein the barrier-forming composition meets the following requirements: about 0.01%≤C≤0.4%; about 7%≤H≤about 65%; and 0.050%<A; wherein all percentages are by weight of the total composition; wherein C is the carbohydrate gum; H is the humectant; and A is the antimicrobial agent; and wherein the antimicrobial agent is a cationic antimicrobial agent or pharmaceutically acceptable salt thereof; the barrier-forming composition is active to trap, and neutralize or kill microorganisms; wherein the barrier-forming composition has a viscosity of less than 500 cps; wherein the pH of the barrier-forming composition is about 4 to about 7.
17 . The barrier-forming composition of claim 16 , wherein the composition is in the form of a solution.
18 . The barrier-forming composition of claim 16 , wherein the composition is free-flowing and clump free.
19 . The barrier-forming composition of claim 16 , wherein the composition has a broad spectrum antimicrobial property that is effective to kill or neutralize fungal, bacterial, and viral microorganisms.
20 . The barrier-forming composition of claim 16 , wherein the antimicrobial, A, is present in an amount of 0.050%<A<1% by weight of the total composition.Join the waitlist — get patent alerts
Track US2019358149A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.